Выходит 6 номеров в год
ISSN Печать: 0743-4863
ISSN Онлайн: 2162-660X
Indexed in
Nanoformulations for Delivery of Biomolecules: Focus on Liposomal Variants for siRNA Delivery
Краткое описание
The potency of biomolecules assures therapy for as well as prevention of many disorders. However, their stability and delivery to the site of action remain a major challenge for successful therapeutic application. With advantages of nanoformulations, such as systemic environmental protection, controlled and site specific release, many of these bio-molecules have found their place in preventive, curative, or immunization-based therapies. Nanoformulations have indeed become a boon for the delivery of biomolecules with such challenges. Among biomolecules, small interfering RNA (siRNA)−based therapeutics has broad range of applications for disorders that may be pathological, metabolic, or physiological. However, certain challenges with respect to biological and delivery constraints need a priori consideration. From this perspective, liposomal delivery has made substantial progress to meet most of the delivery-related (pharmacokinetic) problems associated with siRNA. Furthermore, need-based development has led to the evolution of variants of liposomes. In this review we focus on the scope of siRNA and the trend of rationalized development of liposomal variants to explore its potential therapeutic implication.
-
Tagalakis Aristides D., Lee Do Hyang D., Bienemann Alison S., Zhou Haiyan, Munye Mustafa M., Saraiva Luisa, McCarthy David, Du Zixiu, Vink Conrad A., Maeshima Ruhina, White Edward A., Gustafsson Kenth, Hart Stephen L., Multifunctional, self-assembling anionic peptide-lipid nanocomplexes for targeted siRNA delivery, Biomaterials, 35, 29, 2014. Crossref
-
Dash Tapan K., Konkimalla V. Badireenath, Formulation and Optimization of Doxorubicin and Biochanin A Combinational Liposomes for Reversal of Chemoresistance, AAPS PharmSciTech, 18, 4, 2017. Crossref
-
Dash Tapan K, Konkimalla Venkata Sai Badireenath, Selection and optimization of nano-formulation of P-glycoprotein inhibitor for reversal of doxorubicin resistance in COLO205 cells, Journal of Pharmacy and Pharmacology, 69, 7, 2017. Crossref
-
Baek Kiheon, Tu Chengyi, Zoldan Janet, Suggs Laura J., Gene Transfection for Stem Cell Therapy, Current Stem Cell Reports, 2, 1, 2016. Crossref
-
Chellappan Dinesh Kumar, Yee Neoh Jia, Kaur Ambar Jeet Singh Bhalqish Jeet, Panneerselvam Jithendra, Madheswaran Thiagarajan, Chellian Jestin, Satija Saurabh, Mehta Meenu, Gulati Monica, Gupta Gaurav, Dua Kamal, Formulation and characterization of glibenclamide and quercetin-loaded chitosan nanogels targeting skin permeation, Therapeutic Delivery, 10, 5, 2019. Crossref